{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-023641","form_type":"8-K","ticker":"IMNM","cik":"0001472012","company_name":"Immunome Inc.","filed_at":"2024-02-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.267324+00:00","generated_at":"2026-06-06T02:13:55.794386+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Immunome prices $200M follow-on offering of 10M shares at $20/share","bullets":["Priced 10,000,000 common shares at $20.00 each; gross proceeds ~$200M before expenses.","Underwriters have 30-day option to purchase up to 1,500,000 additional shares.","Closing expected February 16, 2024, subject to customary conditions.","Proceeds intended for general corporate purposes; J.P. Morgan, Cowen, Leerink, Guggenheim lead offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-023641","json":"https://secwatch.observer/filing/0001104659-24-023641.json","markdown":"https://secwatch.observer/filing/0001104659-24-023641.md","text":"https://secwatch.observer/filing/0001104659-24-023641.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472012/000110465924023641/0001104659-24-023641-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472012/000110465924023641/tm246214d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T02:13:55.794386+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}